1804P APEX-01: First-in-human phase I/II study of ARX517 an anti- prostate-specific membrane antigen (PSMA) antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

John Paul Shen, Russell K. Pachynski, Luke T. Nordquist, Nabil Adra, Mehmet Asım Bilen, Rahul Aggarwal, Zachery R. Reichert, Michael T. Schweizer, Amir Iravani, Sandra Aung, Colin Hessel, Scott T. Tagawa